Results 191 to 200 of about 2,885,946 (243)

The Non-High-Density Lipoprotein Cholesterol (Non-HDL-C) to HDL-C Ratio (NHHR) and Its Association with Chronic Kidney Disease in Chinese Adults with Type 2 Diabetes: A Preliminary Study. [PDF]

Nutrients
Chen X, Liang M, Zhang J, Xu C, Chen L, Hu R, Zhong J.   +6 more
europepmc   +1 more source

Correlation of sdLDL-C and Apob with the degree of cerebral artery stenosis in posterior circulation stroke. [PDF]

Sci Rep
Sun Z, Liu J, Wang A, Si Z.
europepmc   +1 more source

Lomitapide modifies high-density lipoprotein function in homozygous familial hypercholesterolaemia. [PDF]

Eur J Med Res
Hafiane A, Ronca A, Incerti M, Rossi A, Manfredini M, Favari E.   +5 more
europepmc   +1 more source

Lipid profiles, lipid ratios and 28-day mortality risk in non-surgical older patients with critical illnesses: a retrospective cohort study using hospitalization records. [PDF]

Lipids Health Dis
Li Y, Ge J, Geng S, Li Q, Chen X, Zhu Y, Guo X, Gu H, Liu Y.   +8 more
europepmc   +1 more source

Association Between Uric Acid to High-Density Lipoprotein Cholesterol Ratio and Abdominal Aortic Aneurysm: A Single-Center Retrospective Study. [PDF]

J Inflamm Res
Lu D, Si K, Huo G.
europepmc   +1 more source

Comparison of triglyceride glucose index and other insulin resistance indexes in children with overweight and obesity. [PDF]

BMC Endocr Disord
Kalyoncu D, Kavrak Kursun M.
europepmc   +1 more source

Target‐Mediated Modeling of Alirocumab in Adolescents and Children ≥8 to <12 Years of Age Using Phase II and III Data

Clinical Pharmacology in Drug Development, EarlyView.
Abstract A population pharmacokinetic (PK) covariate analysis was conducted utilizing data from adolescents and children ≥8 to <12 years of age with heterozygous familial hypercholesterolemia. One phase II and 1 phase III study were analyzed (121 patients on active treatment).
Pavel Kovalenko, Lutz Harnisch, Jeanne Mendell, Yuhuan Wang, John D. Davis, Albert Thomas DiCioccio   +5 more
wiley   +1 more source

The association between the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol and serum uric acid levels and risk of hyperuricemia in different sex groups: A cross-sectional study. [PDF]

Medicine (Baltimore)
Huang J, Chen C.
europepmc   +1 more source

Model‐Informed Drug Development Applications and Opportunities in mRNA‐LNP Therapeutics

Clinical Pharmacology &Therapeutics, EarlyView.
The utilization of lipid nanoparticles (LNP) for encapsulating mRNA has revolutionized the field of therapeutics, enabling the rapid development of COVID‐19 vaccines and cancer vaccines. However, the clinical development of mRNA‐LNP therapeutics faces numerous challenges due to their complex mechanisms of action and limited clinical experience.
Jiawei Zhou, Rohit Rao, Monica E. Shapiro, Nessy Tania, Cody Herron, Cynthia J. Musante, Jim H. Hughes   +6 more
wiley   +1 more source

The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and risk of prostate cancer: a retrospective study. [PDF]

PeerJ
Bu K, Wang J, Zheng X, Zhang K, Wang D, An H, Tao N.   +6 more
europepmc   +1 more source